Joys of Compounding retweeted
Our @joyscompounding teachers are Biotech's New Builders, Peter Harwin and Tomas Kiselak of Fairmount Funds Management - PERHAPS THE GREATEST BIOTECH INVESTORS IN THE WORLD TODAY and yet you’ve likely never heard of them. 🧬 🚀
And this is their FIRST EVER INTERVIEW of any kind! 🤫
In just 10 years, they've achieved a net MOIC of well over 20X and net IRR's over 35%. But as you’ll hear on this episode, just HOW they’ve done it is even more wild and inspiring. 🤯 📈
If you are a longtime listener of ours, you know Paul and I are kind of obsessed with the idea of enduring excellence. We’re convinced that to be great and stay great requires constant evolution - a trait not commonly embraced in the investing industry.
When Fairmount began, it looked a lot like other institutional quality biotech hedge funds. Investing mainly in public stocks and perhaps an occasional private crossover investment. But the DREAM was never really about picking stocks. It was always to BUILD great businesses that BUILD great drugs that ultimately improve the quality of life and standard of care for patients.
Against all odds and little external support, they began to experiment, tinkering with licensing and drug development via SPVs until eventually the *distraction became the focus*.
Today, Fairmount has founded 17 companies, with 15 already public translating into a combined market cap of over $50 Billion. In concert with their wholly owned incubator, Paragon Laboratories, Inc., they have developed an incredible 55 drugs with 27 already in the clinic and one receiving FDA approval. Companies like @CogentBio , @dianthustx, @ViridianThera , Oruka Therapeutics, @spyretx and of course Apogee Therapeutics, which was recently acquired by @abbvie for close to $11Billion. And in doing so, they have also accomplished something almost singular as investors, literally building their own opportunity set, with close to 95% of their portfolio now invested in Fairmount-founded companies.
Whether you are a biotech investor or not, there are so many valuable lessons in Peter and Tomas’ journey. I’m just so proud of these guys for all they’ve already accomplished for the benefit of humanity and I feel privileged to call them friends and partners.
Grateful for our sponsors @eightsleep and @portraitanalyst as well as our partners @colossusmag and @patrick_oshag
TIMESTAMPS:
(00:00) Peter Harwin & Tomas Kiselak, Co-Founders at Fairmount Funds
(01:37) The best biotech investors you’ve never heard of
(04:17) Betting on biotech when 85% of drugs fail
(12:28) When waiting felt riskier than starting
(17:15) The vision hidden in Fairmount’s first letter
(24:28) Trying to license a drug with no experience
(27:37) Why you don’t need a PhD to master biotech
(33:11) How Peter found his way into biotech
(37:39) How biotech boomed, crashed and recovered
(46:15) How an idea becomes an approved drug
(53:38) Why a new drug takes a decade and a billion dollars
(56:58) Why drug development is harder than building a skyscraper
(01:01:13) Building their first company on a $500K check
(01:13:54) What building companies taught them as investors
(01:22:45) How Fairmount compounded to $7.5B without new capital
(01:29:49) The biotech playbook built around not failing
(01:36:17) Why the job’s not done
(01:41:07) Paragon, the engine behind Fairmount’s companies
(01:45:35) Finding people who can handle setbacks
(01:49:57) How Fairmount moves faster than the rest of biotech
(01:53:26) How Apogee became an $11B exit
(01:59:19) Why it’s still too soon to call AI in biotech
(02:04:47) What Fairmount’s next 10 years look like
(02:09:10) “Everything starts as nothing”
Joys of Compounding retweeted
The Berkshire Beat || November 20
- Warren Buffett's Thanksgiving message
- Berkshire Hathaway execs buy shares
- $BSP CEO Luca Ferrari on @joyscompounding
- Berkshire's Q3 investment activity and more kingswell.io/p/the-berkshire…
Joys of Compounding retweeted
Warren Buffett told Charlie Munger, late in Munger's life:
"It's so interesting now. I would like to stick around for another 30 years if I couldn't participate. If I could just watch."
Sarah Guo gets to participate, and that's why she works so hard.
(From our first conversation with Sarah, Aug. 2024)
My second conversation with Sarah Guo (@saranormous), founder of Conviction.
Sarah's been early to many of this generation's defining companies, and is constantly ranked at the top of the managers LPs most want to invest with.
She knows the small group of 250 people pushing the AI frontier and we discuss what she sees from that vantage point:
- What the people building AI actually believe right now
- How close we are to robots in the home
- The case against an AI monopoly
- Why she's bullish on bio x AI
- Building Conviction
@domcooke wrote the definitive profile of Sarah and Conviction for @colossusmag: "Sarah's Wager". Link in comments.
Enjoy!
TIMESTAMPS
0:00 Intro
1:08 Investing Through the AI Boom
12:06 What AI Researchers Believe
15:44 Compute, Capital & Robotics
24:03 How Sarah Makes Investments
39:24 The Case for Open Source
49:01 America’s Compute Independence
51:32 AI’s New Investment Markets
59:36 Finding Truth & What’s Next
Joys of Compounding retweeted
My second conversation with Sarah Guo (@saranormous), founder of Conviction.
Sarah's been early to many of this generation's defining companies, and is constantly ranked at the top of the managers LPs most want to invest with.
She knows the small group of 250 people pushing the AI frontier and we discuss what she sees from that vantage point:
- What the people building AI actually believe right now
- How close we are to robots in the home
- The case against an AI monopoly
- Why she's bullish on bio x AI
- Building Conviction
@domcooke wrote the definitive profile of Sarah and Conviction for @colossusmag: "Sarah's Wager". Link in comments.
Enjoy!
TIMESTAMPS
0:00 Intro
1:08 Investing Through the AI Boom
12:06 What AI Researchers Believe
15:44 Compute, Capital & Robotics
24:03 How Sarah Makes Investments
39:24 The Case for Open Source
49:01 America’s Compute Independence
51:32 AI’s New Investment Markets
59:36 Finding Truth & What’s Next
Joys of Compounding retweeted
Neil Movva (@neilmovva) started his career at Nvidia, working on GPUs and kernels, and has an unusually deep understanding of inference, from software to chips to power.
We spend a lot of time on each of those layers, how they connect, and where the important tradeoffs are.
What makes this conversation special is how detailed it is (like a 401-level class), yet Neil makes it remarkably clear and easy to follow.
Today he runs Sail Research, a company building infrastructure for agents to make tokens as cheap as possible.
We discuss:
- Latency versus throughput
- Why there are no bad chips, only bad pricing
- The end of kernel engineering
- Buying chips and power no one else wants
- New chip architectures
- Nvidia lore + his contrarian view of the company
- Open source and the frontier labs
I learned a ton. Enjoy!
TIMESTAMPS
0:00 Intro
0:38 Building a “Token Factory”
4:21 The Future of Background Agents
13:09 Nvidia and the GPU Stack
23:27 Chips, Memory, and Transformers
36:14 The Future of AI Training Data
44:32 Chip Scarcity and Compute Arbitrage
52:44 Reinventing the AI Data Center
59:01 Power and the “Scavenger Strategy”
1:10:10 Open vs. Closed AI
Joys of Compounding retweeted
My conversation with @benthompson. Ben has been writing Stratechery for over a decade and remains one of my favorite business thinkers.
We covered a lot. Every important company in the industry and the forces acting on all of them.
- Why he thinks it would be problematic for the US to win the AI race
- Will we run out of money to fund AI
- Google becoming Berkshire Hathaway
- Why ads are amazing
- TSMC, Intel, and Samsung
- Nvidia's invisible price cuts + biggest competitors
- Microsoft, Amazon, Apple, and Meta
I love talking to Ben about everything happening in markets and technology. Enjoy!
TIMESTAMPS
0:00 Intro
0:59 America and the AI Race
8:26 AI’s Funding Problem
15:31 AI’s Capabilities and Limits
20:30 Aggregation Theory, AI, and Ads
31:10 Compute, TSMC, and Intel
47:31 Amazon and Apple’s AI Moats
54:43 The Frontier AI Players
74:07 Nvidia and Commoditized Intelligence
82:52 What Survives an AI Bubble?
Joys of Compounding retweeted
One of the most fun JOC conversations I can recall.
Loved learning from AJ about what makes @thomabravo able to sustain its greatness, why lots of software still wins in the age of AI (and why tennis is the best sport on earth)
@eightsleep @portraitanalyst @colossusmag
@PaulBuser
Our conversation with A.J. Rohde.
A.J. Rohde is a Senior Partner at Thoma Bravo, the world’s largest software-focused investment firm.
We cover how a tennis background can predict good investors, why the software selloff was really just a duration trade unwinding, and the single number a whole company can rally around.
Enjoy!
TIMESTAMPS
0:00:00 Intro
0:00:34 Why Thoma Bravo Recruits Tennis Players
0:17:16 Drumming as an Outlet
0:26:44 The Spirit of Philadelphia
0:37:08 Buying Licenses for Air
0:48:09 Constants Across Five Decades of Software
1:12:45 Data That Survives Hype Cycles
1:33:15 How Range Makes a Better Investor
We're coming out of stealth.
We've built our first racks after a successful A0 tapeout, $1B+ in customer contracts, and $800m raised.
Early customer tests show us achieving SOTA throughput, latency, and power efficiency on inference workloads.
Our first racks ship this summer.
Joys of Compounding retweeted
So proud of my friend Brad Gerstner @altcap! He's been tirelessly (and selflessly) working on this vision for years. To put the joys of compounding to work for every American child. 🇺🇸
We all owe him much respect + gratitude.
Thank you BG! 💙
#lovewins #joysofcompounding
“The promise of economic mobility - to forge a better life - IS the most basic promise of America. And that is the promise of the Invest America Act.”
MUST WATCH from Invest America Founder, Brad Gerstner, @altcap. 🇺🇸🇺🇸🚀
Joys of Compounding retweeted
Will Thorndike - The Rise of Long Duration, Serial Acquisition Holding Companies
Our @joyscompounding teacher today is Will Thorndike, co-founder of @CompoundingLabs and author of acclaimed book, The Outsiders.
This is one of the most foundational JOC sessions we’ve ever done because of how much Will has shaped our combined teaching and investing vocations. 🥰
The Outsiders is considered one of the most impactful business books of the 21st century. Lauded by @WarrenBuffett and so many others, it profiles eight CEOs who dramatically outperformed their peers by focusing not on charisma and cult of personality attributes, but on the more quiet and unconventional craft of resource allocation—measured, rational, often contrarian decisions that compounded to extraordinary heights over time.
But Will’s influence goes far beyond the page. He is a pioneer in the private equity and search fund worlds, having founded Housatonic Partners in 1994 and also helping originate the modern search fund model—backing early-career CEOs to buy and grow businesses with long time horizons and radically aligned incentives.
Since then, he has invested in the majority of the top 20 search fund outcomes to date, including @Asurion, which he recently profiled on his podcast 50X. You may not have heard about Asurion but it is likely the greatest private equity investment of all time, generating a more than 5,000 times multiple on invested capital. 🤯
In more recent years, Will’s taken the best of what he’s learned from the PE and Search worlds and is now developing what we think may be an ENTIRELY NEW ASSET CLASS - long-duration, serial acquisition holding companies.
Here are some of the structural and operational features of these businesses:
- These are newco formations that are effectively capitalized on day 1 at book value
- They focus on buying & building recurring revenue businesses in niche markets
- Radical equity efficiency - with often just $10 - 25 million of equity capital deployed forever
- An ethos of exceptional resource allocation → very much aligned with the Outsiders playbook
- The harnessing of both organic AND inorganic growth with a focus on improvability with the assets they acquire
- And, very importantly, these are investors backing founders with an unlimited time horizon and with a focus on ‘multiple on invested capital’ rather than IRR
The alchemy of these attributes are companies that don’t exist to be sold but rather to eternally flourish ♾ – an asset class that harnesses the joys of compounding better than anything else we’ve come across. 📈
I hope you enjoy this class on the rise of long duration, serial acquisition holding companies with our friend and mentor, the eternal outsider, Will Thorndike!
Links in comments.
Joys of Compounding retweeted
A sample of conversations to come on @InvestLikeBest
- Marc Lasry
- @bgurley and @mjmauboussin together
- @ncsh
- @dittycheria
- 2 hours of Mitch Rales (on @artofinvest)
Joys of Compounding retweeted
I just listened to the excellent @artofinvest discussion with @FoundersPodcast. Super high value per minute, which seems to be the norm with David.
Two of the themes covered were the importance of focus and curiosity in order to do great work.
Reflecting on my own journey, there's always been a tension between those two, with curiosity often winning out and taking me in new directions (at the expense of focus).
Since the ability to do great things while pursuing one's life work compounds with time, by some measures this has been costly in terms of the progress in my career. And watching others pass me by professionally hasn't been without some occasional existential hand-wringing, though I have no real regrets about my decisions.
To that point, towards the end of the episode, David talks about three founders who have led a balanced life (out of over 300 that he's profiled!). This more closely resembles my approach to living and, while I don't have the riches of anyone on David's podcast and no one is writing my biography, I do have enough and know that my work and contribution to my profession and the people in that community have been meaningful. And, more importantly, I enjoy the love and friendship of my wife and children, good health, and close friendships that go back decades.
Needless to say, as you can tell, the episode struck a chord!
Here's a link to the podcast: joincolossus.com/episodes/37…
Joys of Compounding retweeted
Otrolig quote från “The Four Loves” av C.S. Lewis som @PaulBuser läser upp i senaste Art of Investing avsnittet med Ben och David från ACQ.
Beskriver så väl grunden till vad som gör de bästa vännerna, kollegorna, och idrotts- och arbetslagen.















